TIC1 (Transcriptional Intermediary Factor 1), also known as NCoA-1 (Nuclear Receptor Coactivator 1), is a nuclear receptor coactivator that plays a critical role in transcriptional regulation. It functions as a scaffold protein that recruits additional coactivators and chromatin remodeling complexes to enhance gene transcription.
[^1]
| Property | Value | [^2]
|----------|-------|
| **Gene Symbol** | TIC1 |
| **Full Name** | Transcriptional Intermediary Factor 1 |
| **Aliases** | NCoA-1, SRC-1, NRC-1 |
| **Chromosomal Location** | 2p23.3 |
| **NCBIB Gene ID** | [10898](https://www.ncbi.nlm.nih.gov/gene/10898) |
| **OMIM ID** | [603484](https://www.omim.org/entry/603484) |
| **Ensembl ID** | ENSG00000100994 |
| **UniProt ID** | [Q13448](https://www.uniprot.org/uniprot/Q13448) |
| **Associated Diseases** | Breast Cancer, Prostate Cancer, Endometriosis, Alzheimer's Disease |
TIC1 functions as a master transcriptional regulator through several mechanisms:
- Nuclear receptor interaction: Binds to ligand-bound nuclear receptors including estrogen receptor (ER), progesterone receptor (PR), thyroid hormone receptor (TR), and retinoic acid receptor (RAR)
- Histone acetylation recruitment: Recruits p300/CBP histone acetyltransferases to chromatin
- Chromatin remodeling: Attracts SWI/SNF complexes for nucleosome displacement
- Mediator complex recruitment: Facilitates interaction between transcription factors and RNA polymerase II
¶ Protein Domains
TIC1 contains several functional domains:
- N-terminal basic helix-loop-helix (bHLH): DNA binding and protein interactions
- PAS domains (PAS-A, PAS-B): Protein-protein interactions and signal sensing
- Nuclear receptor interaction domain (RID): C-terminal LXXLL motif-mediated receptor binding
- Activation domains (AD1, AD2): Transcriptional activation function
- Steroid hormone signaling: Estrogen, progesterone, androgen responses
- Metabolic gene expression: Glucose, lipid, and energy metabolism
- Cell cycle progression: Regulation of cyclin expression
- Differentiation: Embryonic development and tissue-specific differentiation
- Role: TIC1 modulates expression of genes involved in amyloid processing and neuroinflammation
- Evidence: Altered expression in AD brain tissue; interacts with AP-1 transcription factors
- Mechanism: Dysregulation of TIC1 may affect APP processing and tau phosphorylation pathways
- Breast cancer: Overexpression amplifies estrogen receptor signaling
- Prostate cancer: Enhances androgen receptor activity
- Therapeutic target: SRC-1 inhibitors in clinical development
- Type 2 diabetes: Regulates insulin gene expression
- Obesity: Modulates adipogenesis and lipid metabolism
TIC1 exhibits widespread expression with highest levels in:
- Brain: Cortex, hippocampus, hypothalamus
- Reproductive organs: Breast, prostate, uterus
- Metabolic tissues: Liver, adipose tissue, pancreas
- Muscle: Skeletal muscle
- Selective coactivator modulators: Target specific nuclear receptor-coactivator interactions
- Protein-protein interaction inhibitors: Block TIC1-nuclear receptor binding
- Epigenetic therapies: Modulate histone acetylation dynamics
- Coactivator assays: Used to screen nuclear receptor modulators
- Gene expression profiling: Biomarker for hormone-dependent diseases